Letters |

Time Lag Bias in Publishing Clinical Trials

Aynur Ünalp Arida, MD, MSc
JAMA. 1998;279(24):1952-1953. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-24-jac80011.
Text Size: A A A
Published online


To the Editor.— In his interesting study, Dr Ioannidis1 explores the factors contributing to publication bias in clinical trials. Ascertainment of a differential publication lag after the completion of trials in the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) field provides more evidence for publication bias. Nevertheless, I have reservations about his suggestion that publication lag is a more exact term than publication bias in efficacy trials. Stern and Simes2 identified the delay in the publication of studies with negative results as an additional important factor in publication bias. In this context, I find the efforts of Drs Jadad and Rennie3 to coincide the term time lag bias to the findings of Ioannidis' study, for a delay in publication of results, unfortunate. In an open society, divergence of perspectives provides a healthy environment to discuss the differences and is the main source for progression. However, in scientific circles, the departure from a well-established and defined4 term, such as publication bias, should emerge from a real need for clarification. At present, publication lag is a built-in feature for the time dimension of the term publication bias.


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.